Example collocations logo

Diseases in sentence

1608 examples of Diseases in a sentence

Conversely, the developed countries’ view of the diseases of the developing world is that only three are important: AIDS, tuberculosis, and malaria.
This stems from the power of advocacy constituencies and the recognition that these diseases might threaten the developed world.
As a result, these diseases receive a disproportionate amount of funding for research and control, while other infections kill, blind, deform, and disable many more – the “bottom billion” – who have little access to health care.
These infections are known as the Neglected Tropical Diseases (NTDs).
These are not familiar diseases to people lucky enough to live in the world’s richest countries, but they are household names to hundreds of millions of poor people, who are often infected with more than one of them.
Indeed, whereas the misery that worm diseases cause is extensive and the burden excessive – as much as tuberculosis or malaria – they do not kill immediately.
Other diseases, such as sleeping sickness, transmitted by tsetse flies are fatal if untreated, as is leishmaniasis, if the parasites that cause it – transmitted by tiny sandflies – invade the liver and spleen.
The main challenge is to convince policymakers that there is more to reducing poverty than focusing on just three diseases.
If the international community is serious about alleviating poverty and achieving development goals, tackling the diseases so directly associated with economic misery should be a fundamental objective.
Now is the time to rethink our public-health investments and messaging, and evaluate whether we are getting the best value for our donor dollars, or whether we should do much more to tackle diseases that we have so far largely ignored.
DDT is the most cost-effective agent ever produced for the control of diseases spread by flies and mosquitoes.
By improving diet and raising levels of physical activity, policies to mitigate climate change would result in a dramatic cut in rates of diseases that mean premature death and disability for hundreds of millions of people worldwide.
We are developing new and better vaccines to protect kids from deadly diseases.
The increased competition and new manufacturing approaches created by these companies have made it possible to protect a child against eight major diseases – including tetanus, whooping cough, polio, and tuberculosis – for less than $30.
A joint partnership with GlaxoSmithKline will produce a six-in-one vaccine protecting children against polio and other infectious diseases; another, with Novartis, will produce two vaccines that will protect millions of people in the developing world from typhoid and paratyphoid fevers.
Without protection against deadly diseases like measles, pneumonia, and rotavirus, many of these children are being denied a chance to grow up healthy, attend school, and lead productive lives.
There are also opportunities to prevent lifestyle-related diseases and improve treatment by enabling patients to compare their own data with aggregated data on similar patients.
Non-communicable diseases (NCDs) – such as heart disease, diabetes, and cancer – now account for two-thirds of all deaths worldwide.
By forming partnerships with governments and international and local organizations, companies can help reduce the impact of devastating and costly diseases.
Beyond these diseases, for which there is treatment and tracking, thanks partly to ample awareness, many illnesses go unidentified and continue to strain public-health services.
Likewise, empathy with a handful of children who are, or are believed to be, harmed by vaccines largely drives popular resistance to vaccinating children against dangerous diseases.
The fight against infectious diseases like Ebola is one that affects everyone.
In order to succeed, we must capitalize on the expertise of individuals and groups that have been quietly, diligently, and independently studying such diseases.
They must share with those at the front lines of the battle information about diseases’ natural history, modes of transmission, and risk factors, as well as preclinical data on – and clinical responses to – experimental treatments.
But the result, as we saw after 1914, would be the worst of both worlds – reversal of the economic globalization that spreads technology and power, but reinforcement of negative dimensions of military and ecological globalization, such as war, terror, climate change, and the spread of infectious diseases.
This is not just ancient history, irrelevant in the era of molecular biology: naturally derived compounds, such as taxol, still provide some of the most promising avenues for the treatment of cancers and other diseases.
While GCC countries have made major improvements in hygiene and maternal and child health, they form the global epicenter of chronic non-communicable diseases – such as obesity, diabetes, heart disease, and, increasingly, cancer – that result from lifestyle and diet.
Such partnerships are necessary for confronting the infectious and chronic diseases that threaten communities throughout the region, and they have the added benefit of providing entrepreneurial opportunities for the region’s youth.
Middle Eastern countries need fully integrated, innovation-oriented frameworks for training health-care professionals, so that they can address their current public-health challenges and prepare for new, unexpected ones, such as Middle East respiratory syndrome (commonly referred to as MERS), Ebola, and other infectious diseases that can appear with little or no forewarning.
Health experts have traditionally lumped diseases into two categories: communicable diseases, which are caused predominantly by infection, and non-communicable diseases (NCDs) – that is, everything else.
BackNext